MWM
TNGX icon

Mascoma Wealth Management’s Tango Therapeutics TNGX Stock Holding History

Mascoma Wealth Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$11.3K – 506
2023
Q3 		$11.3K Hold
1,000
– – ﹤0.01% 314
2023
Q2 		$3.83K Hold
1,000
– – ﹤0.01% 415
2023
Q1 		$3.4K Buy
+1,000
New +$5.8K ﹤0.01% 518

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Mascoma Wealth Management's TNGX Position: Q4 2023 in Review

Mascoma Wealth Management sold out of Tango Therapeutics (TNGX) in Q4 2023, closing a stake of 1,000 shares — an estimated $11.3K sold.

Mascoma Wealth Management first reported a position in TNGX in Q1 2023 and held it in 3 quarters. The position peaked at $11.3K in Q3 2023. 121 funds tracked by Wall St. Rank hold TNGX as of Q4 2023.

  • Mascoma Wealth Management reported no remaining Tango Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Mascoma Wealth Management sold 1,000 Tango Therapeutics shares in Q4 2023, an estimated $11.3K.
  • Mascoma Wealth Management first reported a position in Tango Therapeutics in Q1 2023 and held it in 3 quarters.
  • Mascoma Wealth Management's Tango Therapeutics position peaked at $11.3K in Q3 2023.
  • 121 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2023.

Based on Mascoma Wealth Management's 13F filing for Q4 2023, filed 24 Jan 2024.